Dr. Magoola unveils gene therapy breakthrough to transform sickle cell treatment
Dr. Magoola, who is leading Dei BioPharma to develop a manufacturing facility with atleast 26 different units, says the biotech ...
Dr. Magoola, who is leading Dei BioPharma to develop a manufacturing facility with atleast 26 different units, says the biotech ...
Dr. Matthias Magoola, the founder and Chief Executive Officer of Dei Group of Companies, acknowledged and thanked the assistance of ...
© 2024 Ugstandard - Latest News by Digital/New Media company.